MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Medplus Health Services Ltd.
ME
Medplus Health Services Ltd.
CLOSED NSE & BSE Bookbuilding IPO Fresh Capital-cum-Offer for Sale Medplus Health Services IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹796
Issue Price: ₹ 796
Issue Price
₹796
Face Value
₹2
Lot Size
18 shares
Open Date
13 Dec 2021
Close Date
15 Dec 2021
Allotment
20 Dec 2021
Listing Date
23 Dec 2021
Exchange
NSE & BSE
Medplus Health Services IPO About the Company

Incorporated in 2006, Medplus Health Services is India's second-largest pharmacy retailer in terms of the number of stores and revenue. The company offers pharmaceutical and wellness products i.e. medicines, vitamins, medical devices, test kits, and fast-moving consumer goods i.e. home and personal care products, baby care products, sanitizers, soaps, and detergents, etc. It is also the first pharmacy retailer in India to offer an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility.

As of June 31, 2021, the company has a strong pharmacy retail network of 2,165 stores across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. In fiscal 2021, its share of the organized pharmacy retail based on revenue from operations in Chennai, Bangalore, Hyderabad, and Kolkata reported at 30%, 29%, 30%, and 22% respectively. It follows a cluster-based approach for store network expansion wherein it first opens high store density in a populated residential area within a target market. The company's warehouses are located in Bengaluru, Chennai, Hyderabad, Vijaywada, Kolkata, Pune, Bhubaneshwar, Mumbai, and Nagpur.

Competitive strengths

  • Second largest pharmacy retailer company in India.
  • Strong brand name and customer value proposition.
  • Pharmacy retail outlet network of 2000+ stores in Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra.
  • First pharmacy retailer to provide Omni-channel platform to customers.
  • Highly qualified, experienced, and professional management team.
...read more
Medplus Health Services IPO Objects of the Issue
Purpose Amount (₹ Cr)
1 Investment into our Material Subsidiary, Optival for funding working capital requirements of Optival ₹467
2 General corporate purposes ₹106
Medplus Health Services IPO Lead Managers
Axis Capital Ltd. Credit Suisse Securities (India) Pvt.Ltd. Edelweiss Financial Services Ltd. Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Financial Summary Amount In Crore
Metric 30-Sep-21 31-Mar-21 31-Mar-20
Total Assets 1,746 1,566 1,349
Revenue 1,891 3,091 2,888
PAT 66 63 2
Issue Details
Total Shares Offered
17,573,342 (100%)
Pre-Issue Shareholding
111,761,165 shares
Post-Issue Shareholding
119,305,676 shares
UPI Mandate
15 Dec 2021
IPO Analytics Dashboard
LIVE
Medplus Health Services IPO GMP Insights
👤
Retail Demand
Good
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Moderate
Medplus Health Services IPO GMP Strength Score
7 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Medplus Health Services IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB — 8,751,852 (50%) —
💼 NII / HNI — 2,625,556 (15%) —
👤 Retail (RII) — 6,126,297 (35%) —
🧑‍💼 Employee — 69,637 (0%) —
Σ Total — 17,573,342 (100%) —

* Amount calculated at upper price band (₹796) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
🏦
QIB ? 8,751,852 (50%)
50%
💼
NII / HNI ? 2,625,556 (15%)
15%
👤
Retail (RII) ? 6,126,297 (35%)
35%
🧑‍💼
Employee ? 69,637 (0%)
0%
Total Shares Offered 17,573,342 (100%)
Medplus Health Services IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 18
Min. Investment ₹14,328
💼 HNI Investors ?
Min. Lots 14
Min. Shares 252
Min. Investment ₹200,592
🏛️ bHNI (>₹10L) ?
Min. Lots 70
Min. Shares 1,260
Min. Investment ₹1,002,960
Medplus Health Services IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 21 Dec 2021
  2. 2 📂 Credit of Shares to Demat 22 Dec 2021
  3. 3 🔒 Lock-in Period (30%) January 19, 2022
  4. 4 🔒 Lock-in Period (50%) March 20, 2022
Investor Interpretation
  • Retail allocation is good at 35% of the total offering.
  • HNI/NII demand is good at 15%.
  • Institutional (QIB) interest is strong at 50%.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 796  ·  Symbol: —
H —
L —
O —
Medplus Health Services IPO Company Info
📍 707, 7th Floor, 5-9-13, Taramandal Commercial Complex, Saifabad Hyderabad 500 004 Hyderabad, Telangana
Visit Website
Medplus Health Services IPO Registrar
Kfin Technologies Ltd.
Check Allotment Status
Medplus Health Services IPO FAQs
Medplus Health Services IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Medplus Health Services IPO is ₹796 per share. One lot has 18 shares, so the minimum investment is about ₹14,328. It is a Fresh Capital-cum-Offer for Sale issue.
Medplus Health Services IPO opened on 13 Dec 2021 and closed on 15 Dec 2021. Allotment is tentatively finalised on 20 Dec 2021. Shares are listed on NSE & BSE on 23 Dec 2021.
Incorporated in 2006, Medplus Health Services is India's second-largest pharmacy retailer in terms of the number of stores and revenue. The company offers pharmaceutical and wellness products i.e. medicines, vitamins, medical devices, test kits, and fast-moving consumer goods i.
As per the offer document, Medplus Health Services plans to use the IPO proceeds for: 1 Investment into our Material Subsidiary, Optival for funding working capital requirements of Optival (₹467); 2 General corporate purposes (₹106).
The lead managers of Medplus Health Services IPO are Axis Capital Ltd., Credit Suisse Securities (India) Pvt.Ltd., Edelweiss Financial Services Ltd., Nomura Financial Advisory & Securities (India) Pvt.Ltd..
Medplus Health Services IPO is proposed to list on NSE & BSE; it is a Bookbuilding IPO and the issue is a Fresh Capital-cum-Offer for Sale.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.